A Study of Alisertib and Paclitaxel in Patients With Small Cell Lung Cancer (SCLC)
Clinical trial NCT07465757 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07465757
- Sponsor
- Puma Biotechnology, Inc.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-09-30
- Primary completion
- 2028-03-31
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.